Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review
CONCLUSION: Limited reporting of determinants of health inequities in RCTs for SLE in Canada suggests the need for reporting standards to support equity, diversity, and inclusion practices in research.PMID:38339797 | DOI:10.1177/09612033241233032 (Source: Lupus)
Source: Lupus - February 10, 2024 Category: Rheumatology Authors: Megan Thomas Vanay Verma Niloofar Gheshlaghi John Esdaile Antonio Avina-Zubieta Cheryl Barnabe Mark Harrison Mary A De Vera Source Type: research
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review
CONCLUSION: Limited reporting of determinants of health inequities in RCTs for SLE in Canada suggests the need for reporting standards to support equity, diversity, and inclusion practices in research.PMID:38339797 | DOI:10.1177/09612033241233032 (Source: Lupus)
Source: Lupus - February 10, 2024 Category: Rheumatology Authors: Megan Thomas Vanay Verma Niloofar Gheshlaghi John Esdaile Antonio Avina-Zubieta Cheryl Barnabe Mark Harrison Mary A De Vera Source Type: research
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review
CONCLUSION: Limited reporting of determinants of health inequities in RCTs for SLE in Canada suggests the need for reporting standards to support equity, diversity, and inclusion practices in research.PMID:38339797 | DOI:10.1177/09612033241233032 (Source: Lupus)
Source: Lupus - February 10, 2024 Category: Rheumatology Authors: Megan Thomas Vanay Verma Niloofar Gheshlaghi John Esdaile Antonio Avina-Zubieta Cheryl Barnabe Mark Harrison Mary A De Vera Source Type: research
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review
CONCLUSION: Limited reporting of determinants of health inequities in RCTs for SLE in Canada suggests the need for reporting standards to support equity, diversity, and inclusion practices in research.PMID:38339797 | DOI:10.1177/09612033241233032 (Source: Lupus)
Source: Lupus - February 10, 2024 Category: Rheumatology Authors: Megan Thomas Vanay Verma Niloofar Gheshlaghi John Esdaile Antonio Avina-Zubieta Cheryl Barnabe Mark Harrison Mary A De Vera Source Type: research
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review
CONCLUSION: Limited reporting of determinants of health inequities in RCTs for SLE in Canada suggests the need for reporting standards to support equity, diversity, and inclusion practices in research.PMID:38339797 | DOI:10.1177/09612033241233032 (Source: Lupus)
Source: Lupus - February 10, 2024 Category: Rheumatology Authors: Megan Thomas Vanay Verma Niloofar Gheshlaghi John Esdaile Antonio Avina-Zubieta Cheryl Barnabe Mark Harrison Mary A De Vera Source Type: research
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review
CONCLUSION: Limited reporting of determinants of health inequities in RCTs for SLE in Canada suggests the need for reporting standards to support equity, diversity, and inclusion practices in research.PMID:38339797 | DOI:10.1177/09612033241233032 (Source: Lupus)
Source: Lupus - February 10, 2024 Category: Rheumatology Authors: Megan Thomas Vanay Verma Niloofar Gheshlaghi John Esdaile Antonio Avina-Zubieta Cheryl Barnabe Mark Harrison Mary A De Vera Source Type: research
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort
CONCLUSIONS: In this inception cohort, a maximum time of 24 months with a median of 6 months to SLE diagnosis had no apparent negative impact on disease outcomes (damage accrual and mortality).PMID:38334100 | DOI:10.1177/09612033241232821 (Source: Lupus)
Source: Lupus - February 9, 2024 Category: Rheumatology Authors: Romina Nieto Rosana Quintana Ernesto Zavala-Flores Rosa Serrano Karen Roberts Luis J Catoggio Mercedes A Garc ía Guillermo A Berbotto Ver ónica Saurit Eloisa Bonfa Eduardo F Borba Lilian T Lavras Costallat Nilzio A Da Silva Emilia I Sato Joao C Tavares Source Type: research
Granulin in renal tubular epithelia is associated with interstitial inflammation and activates the TLR9-IFN- α pathway in lupus nephritis
CONCLUSION: The expression of GRN in RTECs is associated with interstitial inflammation and therapeutic response. GRN may mediate the activation of the TLR9-IFN-α pathway in RTECs and involve in the micro-environment of inflammatory response in LN.PMID:38334360 | DOI:10.1177/09612033241232575 (Source: Lupus)
Source: Lupus - February 9, 2024 Category: Rheumatology Authors: Lanting Huang Yijun Dai Zhenbo Geng Hongyan He Fuyuan Hong Source Type: research
Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus
CONCLUSION: AdoSLE on High-IS induced lower SARS-CoV-2 vaccine immune responses than Low-IS. Vaccination can increase disease activity and requires close monitoring for disease flare.PMID:38335115 | DOI:10.1177/09612033241232576 (Source: Lupus)
Source: Lupus - February 9, 2024 Category: Rheumatology Authors: Nuntawan Piyaphanee Sirirat Charuvanij Sutheera Thepveera Zheng Quan Toh Paul V Licciardi Anirut Pattaragarn Patimaporn Wongprompitak Kobporn Boonnak Chatkamol Pheerapanyawaranun Kulkanya Chokephaibulkit Source Type: research
Reduced miR-99a-3p levels in systemic lupus erythematosus may promote B cell proliferation via NCAPG and the PI3K/AKT signaling pathway
CONCLUSION: Our research indicates that lower miR-99a-3p expression in SLE B cells appears to boost B cell number via the NCAPG and PI3K/AKT pathways.PMID:38320572 | DOI:10.1177/09612033241232053 (Source: Lupus)
Source: Lupus - February 6, 2024 Category: Rheumatology Authors: Qing-Huan Zhu Ya-Li Zhou Meng Yang Bin-Bin Yang Wen-Ting Cao Li-Mei Yuan Dan-Qi Deng Source Type: research
Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review
Conclusion: This case suggests that telitacicept should be an effective and safe treatment for LH refractory, even to those who failed to belimumab based on the standard treatment, and can reduce the dosage of glucocorticoids.However, further investigations, particularly prospective randomized controlled trials, are warranted to verify our findings and ensure patient safety.PMID:38320748 | DOI:10.1177/09612033241233021 (Source: Lupus)
Source: Lupus - February 6, 2024 Category: Rheumatology Authors: Qiuyu Fan Hongyan Ji Ya Liu Chao Jia Liang Zou Huiqin Yang Source Type: research
Non-invasive prediction of the chronic degree of lupus nephropathy based on ultrasound radiomics
CONCLUSION: ML model based on ultrasound radiomics features can accurately predict the chronic degree of LN, which can provide a valuable reference for clinicians in the treatment strategy of LN patients.PMID:38320976 | DOI:10.1177/09612033231223373 (Source: Lupus)
Source: Lupus - February 6, 2024 Category: Rheumatology Authors: Chen Yin Weihan Xiao Xiaomin Hu Xuebin Liu Huaming Xian Jun Su Chaoxue Zhang Xiachuan Qin Source Type: research
Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China
CONCLUSION: Different COVID-19 outcomes in people with SLE are mostly driven by COVID-19 vaccination, medications, and activity SLE. More importantly, three doses of COVID-19 vaccination may be associated with better outcomes.PMID:38314781 | DOI:10.1177/09612033241230736 (Source: Lupus)
Source: Lupus - February 5, 2024 Category: Rheumatology Authors: Peng-Cheng Liu Min Zhang Jian-Bin Li Yi-Lin Peng Shu-Jiao Yu Rui Wu Source Type: research
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score
CONCLUSION: Physicians should carefully and systematically assess the presence of NP features at diagnosis and early stages of j-SLE. For j-NPSLE patients with predominant psychiatric features, a multidisciplinary collaboration, including psychiatrists, is essential for the diagnosis, management and follow-up.PMID:38315109 | DOI:10.1177/09612033241229022 (Source: Lupus)
Source: Lupus - February 5, 2024 Category: Rheumatology Authors: Mathilde Labouret Vincent Trebossen Alexandra Ntorkou Sophie Bartoli M élodie Aubart St éphane Auvin Brigitte Bader-Meunier V éronique Baudouin Olivier Corseri Glory Dingulu Camille Ducrocq C écile Dumaine Monique Elmaleh Nicole Fabien Albert Faye Isa Source Type: research
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series
CONCLUSION: Cases of SLE associated with COVID-19 vaccination against are infrequent. However, clinical monitoring is recommended for persons receiving the SARS-CoV-2 vaccine, mainly those receiving the first dose and the Pfizer-BioNTech-162b2 vaccine.PMID:38315894 | DOI:10.1177/09612033241232054 (Source: Lupus)
Source: Lupus - February 5, 2024 Category: Rheumatology Authors: Nelson Luis Cahuapaza-Gutierrez Source Type: research
